Redeye briefly comments on Physitrack’s announcement to streamline its subsidiary, Champion Health, and the settlement of the share purchase (earnout) agreement. The rationalisation of Champion Health targets annual cost savings of GBP0.4m, with GBP0.2m expected in 2025.
LÄS MER